| Product Code: ETC4720314 | Publication Date: Nov 2023 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
Bulgaria`s human insulin import Market Top 5 Importing Countries and Market Competition (HHI) Analysis showed high concentration levels in 2023, which significantly increased to very high concentration in 2024. The top countries exporting human insulin to Bulgaria in 2024 were Italy, USA, Sweden, Germany, and UK. The Market Top 5 Importing Countries and Market Competition (HHI) Analysis saw impressive growth with a CAGR of 20.01% from 2020 to 2024, although there was a sharp decline in growth rate from 2023 to 2024 at -79.06%. This shift in concentration and growth rates indicates a dynamic and evolving landscape for human insulin imports in Bulgaria.

The human insulin market in Bulgaria is growing due to the increasing prevalence of diabetes and the need for effective insulin therapy. Human insulin is used to manage blood glucose levels in diabetic patients. Market growth is driven by advancements in insulin formulations, rising demand for diabetes management solutions, and the expansion of healthcare services.
The human insulin market in Bulgaria is driven by the increasing prevalence of diabetes and the need for effective diabetes management solutions. Government initiatives and advancements in insulin delivery technologies support market growth.
The human insulin market faces challenges related to pricing pressures and competition from biosimilar products. Regulatory hurdles and the need for extensive clinical trials can delay product approvals and increase development costs. Additionally, managing supply chain complexities and ensuring consistent product quality are critical for maintaining market position. The market is also influenced by changes in healthcare policies and insurance coverage, which can impact the affordability and accessibility of insulin products.
The human insulin market in Bulgaria is shaped by government policies that focus on improving public health and supporting advancements in diabetes care. The Bulgarian government supports the development and use of human insulin to enhance treatment options for diabetes patients. Policies emphasize the importance of integrating advanced insulin technologies into healthcare systems to improve patient outcomes and access to care. Additionally, the government provides incentives for investments in insulin technologies to support industry growth and healthcare advancements.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bulgaria Human Insulin Market Overview |
3.1 Bulgaria Country Macro Economic Indicators |
3.2 Bulgaria Human Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Bulgaria Human Insulin Market - Industry Life Cycle |
3.4 Bulgaria Human Insulin Market - Porter's Five Forces |
3.5 Bulgaria Human Insulin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Bulgaria Human Insulin Market Revenues & Volume Share, By Diabetes Type, 2021 & 2031F |
3.7 Bulgaria Human Insulin Market Revenues & Volume Share, By Delivery Devices, 2021 & 2031F |
3.8 Bulgaria Human Insulin Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Bulgaria Human Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Bulgaria |
4.2.2 Growing awareness about the importance of insulin therapy |
4.2.3 Technological advancements in insulin delivery devices |
4.3 Market Restraints |
4.3.1 High cost associated with insulin treatments |
4.3.2 Limited access to healthcare facilities in rural areas |
4.3.3 Stringent regulatory requirements for insulin products |
5 Bulgaria Human Insulin Market Trends |
6 Bulgaria Human Insulin Market Segmentations |
6.1 Bulgaria Human Insulin Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Bulgaria Human Insulin Market Revenues & Volume, By Analogue Insulin, 2021-2031F |
6.1.3 Bulgaria Human Insulin Market Revenues & Volume, By Traditional Human Insulin, 2021-2031F |
6.2 Bulgaria Human Insulin Market, By Diabetes Type |
6.2.1 Overview and Analysis |
6.2.2 Bulgaria Human Insulin Market Revenues & Volume, By Type 1 Diabetes, 2021-2031F |
6.2.3 Bulgaria Human Insulin Market Revenues & Volume, By Type 2 Diabetes, 2021-2031F |
6.2.4 Bulgaria Human Insulin Market Revenues & Volume, By Gestational Diabetes, 2021-2031F |
6.2.5 Bulgaria Human Insulin Market Revenues & Volume, By Prediabetes, 2021-2031F |
6.3 Bulgaria Human Insulin Market, By Delivery Devices |
6.3.1 Overview and Analysis |
6.3.2 Bulgaria Human Insulin Market Revenues & Volume, By Syringes, 2021-2031F |
6.3.3 Bulgaria Human Insulin Market Revenues & Volume, By Pens, 2021-2031F |
6.3.4 Bulgaria Human Insulin Market Revenues & Volume, By Pumps, 2021-2031F |
6.3.5 Bulgaria Human Insulin Market Revenues & Volume, By Others, 2021-2031F |
6.4 Bulgaria Human Insulin Market, By End-users |
6.4.1 Overview and Analysis |
6.4.2 Bulgaria Human Insulin Market Revenues & Volume, By Home Healthcare, 2021-2031F |
6.4.3 Bulgaria Human Insulin Market Revenues & Volume, By Hospitals, 2021-2031F |
6.4.4 Bulgaria Human Insulin Market Revenues & Volume, By Over The Counter (OTC), 2021-2031F |
6.4.5 Bulgaria Human Insulin Market Revenues & Volume, By Clinics, 2021-2031F |
6.4.6 Bulgaria Human Insulin Market Revenues & Volume, By Others, 2021-2031F |
7 Bulgaria Human Insulin Market Import-Export Trade Statistics |
7.1 Bulgaria Human Insulin Market Export to Major Countries |
7.2 Bulgaria Human Insulin Market Imports from Major Countries |
8 Bulgaria Human Insulin Market Key Performance Indicators |
8.1 Average time taken for insulin prescription fulfillment |
8.2 Rate of adoption of new insulin therapies |
8.3 Number of diabetes education programs conducted in Bulgaria |
9 Bulgaria Human Insulin Market - Opportunity Assessment |
9.1 Bulgaria Human Insulin Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Bulgaria Human Insulin Market Opportunity Assessment, By Diabetes Type, 2021 & 2031F |
9.3 Bulgaria Human Insulin Market Opportunity Assessment, By Delivery Devices, 2021 & 2031F |
9.4 Bulgaria Human Insulin Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 Bulgaria Human Insulin Market - Competitive Landscape |
10.1 Bulgaria Human Insulin Market Revenue Share, By Companies, 2024 |
10.2 Bulgaria Human Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |